4.7 Article

Construction of macroporous magnesium phosphate-based bone cement with sustained drug release

Journal

MATERIALS & DESIGN
Volume 200, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.matdes.2021.109466

Keywords

Magnesium phosphate-based bone cements; Gelatine microspheres; Degradation behaviour; Macroporous; Sustained drug release

Funding

  1. National Key Research and Development Program of China [2018YFB1105500, 2016YFC1101605]
  2. National Natural Science Foundation of China [51772233, 51672206]
  3. Major Special Project of Technological Innovation of Hubei Province [2019ACA130]
  4. Key Basic Research Program of Shenzhen [JCYJ20200109150218836]
  5. Application Foundation and Front Research Program of Wuhan [2018010401011273]
  6. Foshan Xianhu Laboratory of the Advanced Energy Science and Technology Guangdong Laboratory [XHT2020-008]

Ask authors/readers for more resources

In this study, gelatine microspheres were incorporated into magnesium phosphate-based bone cements to improve their physicochemical properties, biocompatibility, biodegradation, and drug release behavior. The results demonstrated that the gelatine microspheres enhanced the setting time, compression strength, macroporosity, and sustained drug release of the composites. This innovative approach shows promise for developing biocompatible bone cements with improved properties.
Magnesium phosphate-based bone cements (MPBCs) have been widely applied in orthopedic and dental fields owing to their excellent self-setting ability and high strength. However, their lack of macroporosity and poor drug release properties restrict their use. In this study, we incorporated various degrees of cross-linking of gelatine microspheres (GM) into MPBC and improved the physicochemical and biocompatible properties, biodegradation and drug release behaviour of the composites. Diclofenac sodium (DS) was utilized as a model drug. Through experiments and observations, we found that the GM induced an adjustable setting time (12 min-16 min), high compression strength (23 MPa-58 MPa), abundant macropores (30.2%-37.8%) and sustained DS release with the double exponential biphasic kinetic model (more than 2 months) into the MPBC composites. Moreover, the sustained release of magnesium and calcium ions had a synergistic effect with GM on the proliferation, osteogenesis differentiation, mineralization ability and gene expression (COL I, OPN, and Runx2) of MC3T3-E1 cells. Subcutaneous implantation and histological analyses indicated that the MPBC-GM composites activated angiogenesis without inducing severe inflammatory reactions. In brief, we prepared biocompatible MPBC composites with adjustable physicochemical properties, formation of macropores, degradation and drug release behaviour. (C) 2021 The Author(s). Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available